Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasms × Gels × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Condylomata Acuminata 3 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Keratosis, Actinic 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Wounds and Injuries 1 Virus Diseases 1 Usual Type Vulval Intraepithelial Neoplasia (uVIN) 1 Squamous Intraepithelial Lesions 1 Skin Neoplasms 1 Sexually Transmitted Diseases 1 Parapsoriasis 1 Papillomavirus Infections 1 Non-Melanoma Skin Cancers 1 Neoplasms 1 Keratosis, Seborrheic 1 Hypogonadism 1 Hemangioma, Cavernous 1 Hemangioma 1 Fatigue 1 Exanthema 1 Eunuchism 1 Dermatitis, Contact 1 Colorectal Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Cancer Pain 1 Breast Carcinoma In Situ 1

Interventions

Bevacizumab 46 Gemcitabine 45 Cyclophosphamide 41 Carboplatin 37 Docetaxel 35 Fluorouracil 32 Cisplatin 32 Paclitaxel 31 pembrolizumab 30 Oxaliplatin 26 Radiotherapy 24 Irinotecan 24 Capecitabine 24 Leucovorin 22 Dexamethasone 21 Cetuximab 21 Nivolumab 19 Doxorubicin 19 Pemetrexed 18 Drug Therapy 18 Erlotinib Hydrochloride 17 Trastuzumab 15 Rituximab 15 Prednisone 15 durvalumab 14 fludarabine 13 atezolizumab 13 Sorafenib 13 Lapatinib 13 Everolimus 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04301765 2025-03-11

TEMEC

Seattle Institute for Biomedical and Clinical Research

Phase 2 Recruiting

Eunuchism, Fatigue, Hypogonadism, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡